Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17839739 | 0.79 | PLK4 (0.30) | — | |
| SCHEMBL1638399 | 0.76 | CCNE1 (0.45) | — | |
| SCHEMBL5419829 | 0.75 | ALDH1A1 (0.41) | RAB9ANPC1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL18791158 | 0.74 | PSMB8 (0.58) | SMN1; SMN2ALDH1A1MAPTTDP1 | |
| SCHEMBL15881078 | 0.73 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL15880354 | 0.73 | CLK1 (0.36) | RAB9ANPC1ALDH1A1TDP1KDM4E | |
| SCHEMBL11331664 | 0.72 | TYMS (0.43) | SMN1; SMN2ALDH1A1MAPTTDP1HTT | |
| SCHEMBL11106009 | 0.71 | LIPG (0.38) | SMN1; SMN2ALDH1A1TDP1KDM4EHTT | |
| SCHEMBL24820021 | 0.70 | HDAC3 (0.44) | RAB9ANPC1ALDH1A1 | |
| SCHEMBL19783341 | 0.70 | KMT2A (0.36) | RAB9ANPC1SMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2630179-B1 | CONJUGATED POLYMERS | RAYNERGY TEK INC (TW) | 2021-04-14 | — | — | EP | disclosed |
| US-9570688-B2 | Semiconductor materials prepared from bridged bithiazole copolymers | BASF SE (DE) | 2017-02-14 | — | — | US | disclosed |
| US-9570688-B2 | Semiconductor materials prepared from bridged bithiazole copolymers | BASF SE (DE) | 2017-02-14 | — | — | US | disclosed |
| US-9559303-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2017-01-31 | — | — | US | disclosed |
| EP-2601236-B1 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS | BASF SE (DE) | 2016-11-02 | — | — | EP | disclosed |
| US-20150162546-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COMPOLYERS | BASF SE (DE) | 2015-06-11 | — | — | US | disclosed |
| US-20150162546-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COMPOLYERS | BASF SE (DE) | 2015-06-11 | — | — | US | disclosed |
| US-20130214208-A1 | Conjugated Polymers | MERCK PATENT GMBH (DE) | 2013-08-22 | — | — | US | disclosed |
| US-20130144065-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS | POLYERA CORPORATION (US) | 2013-06-06 | — | — | US | disclosed |
| US-20130144065-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS | POLYERA CORPORATION (US) | 2013-06-06 | — | — | US | disclosed |
| WO-2012016925-A2 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS | BASF SE (DE) | 2012-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150162546-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COMPOLYERS | CBS, SULT1A1, GSTA1 | RAB9A 3942/4885NPC1 1436/4885SMN1; SMN2 3496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.